A Transfer Learning and Explainable Solution to Detect mpox from Smartphones images
This work addresses the need for preliminary screening of mpox in low-income countries with inadequate healthcare infrastructure, though it is incremental as it applies existing methods to a new medical dataset.
The authors tackled the problem of detecting mpox from skin lesion images using deep learning, achieving a feasible solution with optimized models for mobile devices through transfer learning and quantization, validated by classification quality, memory footprint, and processing times.
In recent months, the monkeypox (mpox) virus -- previously endemic in a limited area of the world -- has started spreading in multiple countries until being declared a ``public health emergency of international concern'' by the World Health Organization. The alert was renewed in February 2023 due to a persisting sustained incidence of the virus in several countries and worries about possible new outbreaks. Low-income countries with inadequate infrastructures for vaccine and testing administration are particularly at risk. A symptom of mpox infection is the appearance of skin rashes and eruptions, which can drive people to seek medical advice. A technology that might help perform a preliminary screening based on the aspect of skin lesions is the use of Machine Learning for image classification. However, to make this technology suitable on a large scale, it should be usable directly on mobile devices of people, with a possible notification to a remote medical expert. In this work, we investigate the adoption of Deep Learning to detect mpox from skin lesion images. The proposal leverages Transfer Learning to cope with the scarce availability of mpox image datasets. As a first step, a homogenous, unpolluted, dataset is produced by manual selection and preprocessing of available image data. It will also be released publicly to researchers in the field. Then, a thorough comparison is conducted amongst several Convolutional Neural Networks, based on a 10-fold stratified cross-validation. The best models are then optimized through quantization for use on mobile devices; measures of classification quality, memory footprint, and processing times validate the feasibility of our proposal. Additionally, the use of eXplainable AI is investigated as a suitable instrument to both technically and clinically validate classification outcomes.